This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.
CLSI NBS05
Original price was: $180.00.$90.00Current price is: $90.00.
Newborn Screening for Cystic Fibrosis, 2nd Edition, NBS05Ed2E
Clinical and Laboratory Standards Institute , 12/01/2019
Pages: 86
